Tapewire

Nasdaq · USD

BIIB

BIOGEN INC.

Export transactions ↓
Tapewire entity
1675
SEC CIK
0000875045
Parsed reports
468

Last 12 months

Inside the activity.

1 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202612
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 10, 2025 Filed Feb 12, 2025 22:48 UTC
Singhal PriyaHead of Development
Tax withholdingCommon Stock 357 $142.54 $50,886.78
Disclosure

SEC source: 0001127602-25-004462 · form4.xml · nonDerivative · entry 2

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,066.4761

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:48 UTC
Singhal PriyaHead of Development
Exercise / conversionCommon Stock 1,212 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004462 · form4.xml · nonDerivative · entry 1

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,423.4761

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:47 UTC
Murphy NicoleHead of Pharm Ops and Tech
Exercise / conversionRestricted Stock Unit · Derivative 2,272 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004461 · form4.xml · derivative · entry 3

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,272 shares

Expires 2025-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:47 UTC
Murphy NicoleHead of Pharm Ops and Tech
Tax withholdingCommon Stock 670 $142.54 $95,501.80
Disclosure

SEC source: 0001127602-25-004461 · form4.xml · nonDerivative · entry 2

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,055.3741

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:47 UTC
Murphy NicoleHead of Pharm Ops and Tech
Exercise / conversionCommon Stock 2,272 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004461 · form4.xml · nonDerivative · entry 1

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,725.3741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:46 UTC
McDonnell Michael R.EVP, Chief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,257 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004459 · form4.xml · derivative · entry 3

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,257 shares

Expires 2025-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:46 UTC
McDonnell Michael R.EVP, Chief Financial Officer
Tax withholdingCommon Stock 1,371 $142.54 $195,422.34
Disclosure

SEC source: 0001127602-25-004459 · form4.xml · nonDerivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,341

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:46 UTC
McDonnell Michael R.EVP, Chief Financial Officer
Exercise / conversionCommon Stock 3,257 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004459 · form4.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,712

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:44 UTC
Kramer RobinChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 834 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004457 · form4.xml · derivative · entry 3

Kramer Robin · CIK 0001609222 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 834 shares

Expires 2025-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:44 UTC
Kramer RobinChief Accounting Officer
Tax withholdingCommon Stock 245 $142.54 $34,922.30
Disclosure

SEC source: 0001127602-25-004457 · form4.xml · nonDerivative · entry 2

Kramer Robin · CIK 0001609222 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,011.7483

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:44 UTC
Kramer RobinChief Accounting Officer
Exercise / conversionCommon Stock 834 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004457 · form4.xml · nonDerivative · entry 1

Kramer Robin · CIK 0001609222 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,256.7483

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:43 UTC
Gregory GingerEVP, Human Resources
Exercise / conversionRestricted Stock Unit · Derivative 2,159 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004456 · form4.xml · derivative · entry 3

Gregory Ginger · CIK 0001545716 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,159 shares

Expires 2025-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:43 UTC
Gregory GingerEVP, Human Resources
Tax withholdingCommon Stock 634 $142.54 $90,370.36
Disclosure

SEC source: 0001127602-25-004456 · form4.xml · nonDerivative · entry 2

Gregory Ginger · CIK 0001545716 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,598.1006

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:43 UTC
Gregory GingerEVP, Human Resources
Exercise / conversionCommon Stock 2,159 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004456 · form4.xml · nonDerivative · entry 1

Gregory Ginger · CIK 0001545716 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,232.1006

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:42 UTC
ALEXANDER SUSAN HEVP Chief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 2,575 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004454 · form4.xml · derivative · entry 4

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,575 shares

Expires 2025-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:42 UTC
ALEXANDER SUSAN HEVP Chief Legal Officer
Tax withholdingCommon Stock 807 $142.54 $115,029.78
Disclosure

SEC source: 0001127602-25-004454 · form4.xml · nonDerivative · entry 2

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,265

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:42 UTC
ALEXANDER SUSAN HEVP Chief Legal Officer
Exercise / conversionCommon Stock 2,575 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004454 · form4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,072

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:40 UTC
Izzar RachidHead of Global Product Strat.
Exercise / conversionRestricted Stock Unit · Derivative 1,515 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004452 · form4.xml · derivative · entry 3

Izzar Rachid · CIK 0001875506 · Head of Global Product Strat.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,515 shares

Expires 2025-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:40 UTC
Izzar RachidHead of Global Product Strat.
Tax withholdingCommon Stock 445 $142.54 $63,430.30
Disclosure

SEC source: 0001127602-25-004452 · form4.xml · nonDerivative · entry 2

Izzar Rachid · CIK 0001875506 · Head of Global Product Strat.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,553

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:40 UTC
Izzar RachidHead of Global Product Strat.
Exercise / conversionCommon Stock 1,515 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004452 · form4.xml · nonDerivative · entry 1

Izzar Rachid · CIK 0001875506 · Head of Global Product Strat.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,998

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:59 UTC
McDonnell Michael R.EVP, Chief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 2,216 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003964 · form4.xml · derivative · entry 6

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,434

Underlying: Common Stock · 2,216 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:59 UTC
McDonnell Michael R.EVP, Chief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 2,335 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003964 · form4.xml · derivative · entry 5

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,335

Underlying: Common Stock · 2,335 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:59 UTC
McDonnell Michael R.EVP, Chief Financial Officer
Tax withholdingCommon Stock 716 $141.35 $101,206.60
Disclosure

SEC source: 0001127602-25-003964 · form4.xml · nonDerivative · entry 4

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,455

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:59 UTC
McDonnell Michael R.EVP, Chief Financial Officer
Exercise / conversionCommon Stock 2,216 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003964 · form4.xml · nonDerivative · entry 3

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:59 UTC
McDonnell Michael R.EVP, Chief Financial Officer
Tax withholdingCommon Stock 786 $141.35 $111,101.10
Disclosure

SEC source: 0001127602-25-003964 · form4.xml · nonDerivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,955

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:59 UTC
McDonnell Michael R.EVP, Chief Financial Officer
Exercise / conversionCommon Stock 2,335 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003964 · form4.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:55 UTC
Viehbacher ChristopherDirector · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 9,008 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003962 · form4.xml · derivative · entry 4

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,017

Underlying: Common Stock · 9,008 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:55 UTC
Viehbacher ChristopherDirector · President and CEO
Tax withholdingCommon Stock 3,201 $141.35 $452,461.35
Disclosure

SEC source: 0001127602-25-003962 · form4.xml · nonDerivative · entry 2

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,807

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:55 UTC
Viehbacher ChristopherDirector · President and CEO
Exercise / conversionCommon Stock 9,008 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003962 · form4.xml · nonDerivative · entry 1

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:52 UTC
Grogan JaneHead of Research
Exercise / conversionRestricted Stock Unit · Derivative 1,385 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003961 · form4.xml · derivative · entry 4

Grogan Jane · CIK 0001995547 · Head of Research

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,770

Underlying: Common Stock · 1,385 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:52 UTC
Grogan JaneHead of Research
Tax withholdingCommon Stock 443 $141.35 $62,618.05
Disclosure

SEC source: 0001127602-25-003961 · form4.xml · nonDerivative · entry 2

Grogan Jane · CIK 0001995547 · Head of Research

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,433

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:52 UTC
Grogan JaneHead of Research
Exercise / conversionCommon Stock 1,385 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003961 · form4.xml · nonDerivative · entry 1

Grogan Jane · CIK 0001995547 · Head of Research

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,876

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:51 UTC
Keeney AdamHead of Corporate Development
Exercise / conversionRestricted Stock Unit · Derivative 1,801 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003960 · form4.xml · derivative · entry 4

Keeney Adam · CIK 0001973607 · Head of Corporate Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,604

Underlying: Common Stock · 1,801 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:51 UTC
Keeney AdamHead of Corporate Development
Tax withholdingCommon Stock 563 $141.35 $79,580.05
Disclosure

SEC source: 0001127602-25-003960 · form4.xml · nonDerivative · entry 2

Keeney Adam · CIK 0001973607 · Head of Corporate Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,900

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:51 UTC
Keeney AdamHead of Corporate Development
Exercise / conversionCommon Stock 1,801 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003960 · form4.xml · nonDerivative · entry 1

Keeney Adam · CIK 0001973607 · Head of Corporate Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,463

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:48 UTC
Kramer RobinChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 703 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003958 · form4.xml · derivative · entry 7

Kramer Robin · CIK 0001609222 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,407

Underlying: Common Stock · 703 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:48 UTC
Kramer RobinChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 788 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003958 · form4.xml · derivative · entry 6

Kramer Robin · CIK 0001609222 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 789

Underlying: Common Stock · 788 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:48 UTC
Kramer RobinChief Accounting Officer
Tax withholdingCommon Stock 244 $141.35 $34,489.40
Disclosure

SEC source: 0001127602-25-003958 · form4.xml · nonDerivative · entry 4

Kramer Robin · CIK 0001609222 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,422.7483

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:48 UTC
Kramer RobinChief Accounting Officer
Exercise / conversionCommon Stock 703 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003958 · form4.xml · nonDerivative · entry 3

Kramer Robin · CIK 0001609222 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,666.7483

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:48 UTC
Kramer RobinChief Accounting Officer
Tax withholdingCommon Stock 232 $141.35 $32,793.20
Disclosure

SEC source: 0001127602-25-003958 · form4.xml · nonDerivative · entry 2

Kramer Robin · CIK 0001609222 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,963.7483

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:48 UTC
Kramer RobinChief Accounting Officer
Exercise / conversionCommon Stock 788 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003958 · form4.xml · nonDerivative · entry 1

Kramer Robin · CIK 0001609222 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,195.7483

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:47 UTC
Murphy NicoleHead of Pharm Ops and Tech
Exercise / conversionRestricted Stock Unit · Derivative 1,940 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003957 · form4.xml · derivative · entry 7

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,880

Underlying: Common Stock · 1,940 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:47 UTC
Murphy NicoleHead of Pharm Ops and Tech
Exercise / conversionRestricted Stock Unit · Derivative 2,102 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003957 · form4.xml · derivative · entry 6

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,102

Underlying: Common Stock · 2,102 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:47 UTC
Murphy NicoleHead of Pharm Ops and Tech
Tax withholdingCommon Stock 603 $141.35 $85,234.05
Disclosure

SEC source: 0001127602-25-003957 · form4.xml · nonDerivative · entry 4

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,453.3741

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:47 UTC
Murphy NicoleHead of Pharm Ops and Tech
Exercise / conversionCommon Stock 1,940 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003957 · form4.xml · nonDerivative · entry 3

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,056.3741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:47 UTC
Murphy NicoleHead of Pharm Ops and Tech
Tax withholdingCommon Stock 620 $141.35 $87,637.00
Disclosure

SEC source: 0001127602-25-003957 · form4.xml · nonDerivative · entry 2

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,116.3741

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:47 UTC
Murphy NicoleHead of Pharm Ops and Tech
Exercise / conversionCommon Stock 2,102 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003957 · form4.xml · nonDerivative · entry 1

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,736.3741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:45 UTC
Singhal PriyaHead of Development
Exercise / conversionRestricted Stock Unit · Derivative 2,216 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003956 · form4.xml · derivative · entry 4

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,434

Underlying: Common Stock · 2,216 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:45 UTC
Singhal PriyaHead of Development
Tax withholdingCommon Stock 681 $141.35 $96,259.35
Disclosure

SEC source: 0001127602-25-003956 · form4.xml · nonDerivative · entry 2

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,211.4761

Read SEC document
February 07, 2025 Filed Feb 10, 2025 23:45 UTC
Singhal PriyaHead of Development
Exercise / conversionCommon Stock 2,216 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003956 · form4.xml · nonDerivative · entry 1

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,892.4761

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.